Active, not recruitingPhase 2NCT04640025

A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib

Studying Bronchiolitis obliterans

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Incyte Corporation
Principal Investigator
Lance Leopold, MD
Incyte Corporation
Intervention
itacitinib(drug)
Enrollment
18 enrolled
Eligibility
18 years · All sexes
Timeline
20212026

Study locations (21)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04640025 on ClinicalTrials.gov

Other trials for Bronchiolitis obliterans

Additional recruiting or active studies for the same condition.

See all trials for Bronchiolitis obliterans

← Back to all trials